Genevieve Laforet

Company: Aspa Therapeutics
Job title: Vice President - Clinical Development
Seminars:
Complement Activation & Thrombotic Microangiopathy Associated with AAV Gene Therapy 1:30 pm
Overview of the complement system and complementopathies Thrombotic microangiopathy (TMA) associated with AAV gene therapy: atypical hemolytic-uremic syndrome (aHUS) Case characteristics of AAV-associated TMA/aHUS Surveillance, diagnosis and managementRead more
day: Day Two